Patients prescribed proton pump inhibitors had roughly double the risk of community-associated Clostridioides difficile infection compared with those not taking the drugs. Patients who use proton pump ...

Frequently, when people hear about Clostridium difficile, they think of hospitals or other healthcare settings. New research, however, suggests the bacterium may be more common in the general ...

A new study looked at Clostridioides difficile infection (CDI) in outpatient settings and found the bacteria may be underdiagnosed, according to a study out Jan. 11 in Open Forum Infectious Diseases.

Community exposure to the superbug Clostridiodes difficile may be more common than previously thought, with a surprising amount of spores carried on the soles of shoes, a new study has found. C. diff ...

Community-acquired Clostridium difficile (C. difficile) infection occurred in a significant proportion of people with no recent exposure to antibiotics, with 53% having no exposure in the 45 days ...

CANTON, Mass.--(BUSINESS WIRE)--Since implementing new Expanse workflows and tools in early 2022, Southern Ohio Medical Center (Portsmouth, OH) has seen a 30% relative change in hospital-acquired ...

Fecal microbiota transplantation has become one of the most effective treatments for recurrent Clostridioides difficile infections, but its long-term role in gastroenterology may hinge on moving ...

Primary-care clinicians should be aware that a patient’s diarrhea or abdominal cramps could be the result of infection with Clostridium difficile. Researchers report that infection with this bacterium ...

STATEN ISLAND, N.Y., Sept. 30, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small ...